Toronto, Ontario, Canada, July 17, 2019 – IPS-Integrated Project Services, ULC, a leading provider of Engineering, Procurement, Construction Administration and Validation (EPCAV) services, was selected by BWXT ITG Canada, Inc. to provide Basis of Design and Detailed Design for BWX Technologies, Inc.’s (BWXT) isotope project, specifically the expansion of their medical isotope and radiopharmaceutical facility in Ottawa, Ontario, Canada. BWXT’s project, utilizing breakthrough technology, is for the development and commercialization of Molybdenum-99 (Mo-99) and Technetium-99m (Tc-99m).
Mo-99 is used in Tc-99m generators, which are critical diagnostic medical isotopes, are used globally in over 30 million procedures every year to diagnose a wide range of conditions including cardiac, oncology, neurology, and gastrointestinal disorders.
The IPS Canadian-led project team, based in Toronto, is designing the facility to meet all applicable building standards to be compliant with current GMP regulations to support FDA approval, and consider EMA Annex 1 facility-related requirements to allow sufficient space for future accommodation.
IPS’ internationally recognized experts work collaboratively with BWXT engineering and development teams to safeguard the new design and implementation plan to meet the required facility change and support the demand for critical medical isotopes. Paula Casalino, P.Eng., IPS VP, Operations-Canada, states “Our facility design team and technology specialists work closely to integrate an optimum design solution with complex process and equipment requirements with the sophisticated building systems required to support them.”
“This is an exciting opportunity for IPS to support BWXT’s growth strategy in the ever-expanding medical isotope industry,” said IPS President of the Americas Mark Butler. “Our team of experts in advanced aseptic manufacturing is working closely with BWXT to help them realize their technical innovations at commercial scale quantities; this is at the heart of our approach toward this important project.”
IPS-Integrated Project Services, ULC is the Canadian entity of IPS-Integrated Project Services, LLC, a global leader in developing innovative business solutions for the biotechnology and pharmaceutical industries. Through operational expertise and industry-leading knowledge, skill, and passion, IPS-Integrated Project Services, LLC provides consulting, architecture, engineering, construction management, and compliance services that allow clients to create and manufacture life-impacting products around the world. Headquartered in Blue Bell, PA-USA, IPS-Integrated Project Services, LLC is one of the fastest-growing companies servicing the life sciences industry with over 1,300 professionals in the US, Canada, Brazil, UK, Ireland, Switzerland, Singapore, China, and India. Visit our website at www.ipsdb.com.
Paula Casalino, P.Eng.
VP, Operations, Canada
Daniel J. Colantonio, P.Eng.
Director of Project Management, Canada
Dan Leorda, PE
Global Strategies and Client Development